InvestorsHub Logo
Followers 6
Posts 130
Boards Moderated 0
Alias Born 01/25/2014

Re: Gsdubb post# 4704

Thursday, 01/30/2014 8:19:35 PM

Thursday, January 30, 2014 8:19:35 PM

Post# of 106838
Any information from Bioheart management would prove helpful...I believe BioLeonhardt's stem cell treatment utilizes cardiac progenitor cells that are best implanted in rim-area of the MI scar, as opposed to Myocell being only stem cell functional in scarred myocardium (due to muscle cells ability to survive in hypoxic conditions). The device is different as well...an implantable pump designed to give repeat injections in the myocardium which has been hypothesized to vastly improve results and can be used with any variety of cell-type.